Preoperative neoadjuvant androgen withdrawal therapy in prostate cancer: The Canadian experience - Discussion

被引：0
|
作者：
Kantoff, PW [1 ]
Klotz, L
D'Amico, AV
Smith, MR
Carroll, PR
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Univ Toronto, Toronto, ON, Canada
[3] Brigham & Womens Hosp, Boston, MA 02115 USA
[4] Massachusetts Gen Hosp, Boston, MA 02114 USA
[5] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
UROLOGY | 2002年 / 60卷 / 3A期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：51 / 51
页数：1
相关论文
共 50 条
  • [1] Preoperative neoadjuvant androgen withdrawal therapy in prostate cancer: The Canadian experience
    Hurtado-Coll, A
    Goldenberg, SL
    Klotz, L
    Gleave, ME
    UROLOGY, 2002, 60 (3A) : 45 - 51
  • [2] Intermittent androgen suppression in prostate cancer: The Canadian experience - Discussion
    Oh, WK
    Klotz, L
    Smith, MR
    Carroll, PR
    McLeod, DG
    Sartor, O
    UROLOGY, 2002, 60 (3A) : 56 - 56
  • [3] Intermittent androgen suppression in prostate cancer: The Canadian experience
    Hurtado-Coll, A
    Goldenberg, SL
    Gleave, ME
    Klotz, L
    UROLOGY, 2002, 60 (3A) : 52 - 56
  • [4] Osteoporosis during androgen deprivation therapy for prostate cancer - Discussion
    George, DJ
    Smith, MR
    Sartor, O
    McLeod, DG
    Carroll, PR
    UROLOGY, 2002, 60 (3A) : 86 - 86
  • [5] Morphologic effects of neoadjuvant hormone therapy on prostate cancer -: Discussion
    Civantos, F
    Têtu, B
    Fair, WR
    Bostwick, D
    Trachtenberg, J
    Pienta, KJ
    Gleave, M
    MOLECULAR UROLOGY, 1998, 2 (03) : 109 - 109
  • [6] Neoadjuvant hormonal therapy: The Canadian experience
    Labrie, F
    Cusan, L
    Gomez, JL
    Diamond, P
    Suburu, R
    Lemay, M
    Tetu, B
    Fradet, Y
    Belanger, A
    Candas, B
    UROLOGY, 1997, 49 (3A) : 56 - 64
  • [7] Maximal androgen withdrawal for prostate cancer therapy: current status and future potential
    Leewansangtong, S
    Crawford, ED
    ENDOCRINE-RELATED CANCER, 1998, 5 (04) : 325 - 339
  • [8] Osteoporosis due to androgen deprivation therapy in men with prostate cancer - Discussion
    Newling, DWW
    Daniell, HW
    Lieberman, R
    Sylvester, J
    Trachtenberg, J
    UROLOGY, 2001, 58 (2A) : 106 - 107
  • [9] Is neoadjuvant androgen deprivation therapy beneficial in prostate cancer treated with definitive radiotherapy?
    Eom, Keun-Yong
    Ha, Sung W.
    Lee, Eunsik
    Kwak, Cheol
    Lee, Sang Eun
    RADIATION ONCOLOGY JOURNAL, 2014, 32 (04): : 247 - 255
  • [10] Effect of Neoadjuvant Intense Androgen Deprivation Therapy in Neuroendocrine Differentiation of Prostate Cancer
    Montaser, Laleh
    Calagua, Carla
    Schaefer, Rachel
    Lis, Rosina
    Zhang, Zhenwei
    Loda, Massimo
    Taplin, Mary-Ellen
    Balk, Steven P.
    Ye, Huihui
    LABORATORY INVESTIGATION, 2017, 97 : 244A - 244A
12345